Mayinglong

Mayinglong Pharmaceutical Group Co., Ltd. (600993.SH) was founded in 1582 and is a "China Time-honored Brand" enterprise with 440 years of continuous operation. The company adheres to the development concept of "target customer unification, service function diversification," dedicated to providing professional, personalized, and diversified anal health solutions to customers. It vigorously develops the large health industry, forming a group enterprise integrating four major business sectors: pharmaceuticals industry, large health, medical services, and pharmaceutical commerce. By implementing brand management as its dominant strategy, Mayinglong has adopted a series of "upholding tradition while innovating" strategies to create the image of a "new internet sensation in traditional Chinese medicine." This has maintained the youthful vitality of a 400-year-old brand, making it to the list of "China's 500 Most Valuable Brands" for 18 consecutive years. In 2021, its brand value reached 49.281 billion yuan, ranking 169th. Mayinglong inherits the essence of the 440-year-old "Eight Treasures Formula," innovatively developing leading products such as Eight Treasures Eye Ointment, Mayinglong Musk Hemorrhoid Cream, Musk Hemorrhoid Suppositories, Dragon Pearl Ointment, and Eight Treasures Eye Cream. The company owns over 100 national drug approval numbers and more than 400 SKUs of large health products, forming a "1+4+X" product structure centered on anal care, supported by ophthalmology, dermatology, gynecology, and psycho-oncology categories, with various extensions into the large health domain. Notably, "Mayinglong Eye Medicine Production Techniques" have been listed as a national intangible cultural heritage, and its hemorrhoid treatment ointments have been recognized by China’s Ministry of Industry and Information Technology as "Champion Products in Manufacturing." The Mayinglong Eight Treasures series of eye creams have become an internet hit category. Additionally, leveraging its brand influence in the field of proctology and structural advantages in product industries, the company actively expands medical services and vigorously develops the large health industry. It currently operates over 60 directly managed specialty hospitals and co-built proctology diagnosis and treatment centers. Its large health products include functional skincare, functional care products, functional foods, and anal health products. The company actively promotes intelligent manufacturing construction, possessing internationally leading and domestically top-tier smart production lines for ointments and suppositories, achieving real-time data collection and monitoring. Using visual navigation AGVs, it creates flexible and intelligent logistics, utilizing 5G networks and IoT technology to achieve digital twins of key equipment. It has received honors such as an Internet-based manufacturing "dual innovation" platform, "5G Fully Connected Factory (Park)," "Hubei Province Intelligent Manufacturing Pilot Demonstration Enterprise," and "Hubei Province Cloud Benchmark Enterprise." The company has established four major technological innovation platforms, collaborating with institutions like the Chinese Academy of Sciences, Academy of Military Medical Sciences, Peking University, and Tsinghua University to build joint laboratories. It has set up two research workstations—an academician workstation and a postdoctoral workstation—and has been accredited as a "National Enterprise Technology Center" and "High-tech Enterprise." The company also boasts a team of doctors led by the most influential experts in the field of proctology in China, becoming a leading anal specialty diagnosis and treatment institution in terms of both technology and scale. As the first domestic project to implement a closed-loop internet medical proctology specialty, the Mayinglong Health Cloud Platform focuses on building a specialized and vertical mobile healthcare platform. In June 2021, the company obtained an Internet Medical Institution Practice License, becoming the first private internet hospital in Hubei Province. Mayinglong consistently upholds the spirit of perseverance and dedication, combining the lofty ideals, firm beliefs, and persistent pursuits of dragons with the down-to-earth nature of horses to pursue the harmony of heaven, earth, and humanity. It strives to fulfill its business mission of creating health for customers, wealth for shareholders, opportunities for employees, and benefits for society; advocating a philosophy of "cultivating sincerity and diligence," an operational view of "prudent management and coordinated development," and a value system of "resource enhancement." Through continuous innovative practices, Mayinglong has developed a unique "Three-Dimensional Three-Power Value Creation System" as a practical tool to implement corporate culture. This system won the first prize in the 22nd National Modern Management Innovation Achievements Award.Looking ahead, Mayinglong will continue to deeply cultivate the entire industrial chain of proctology, strengthen its core through a deepening specialization strategy, expand its boundaries, deepen its business models, and extend its foundation. It aims to enhance the operational capabilities and quality of solution systems, product delivery systems, and customer service sales systems, promote model innovations, and achieve high-quality development.